Humana, Monogram’s value-based arrangement aims to improve kidney care
More than one in seven American adults live with chronic kidney disease, which represents 37 million people, according to the Centers for Disaster Control and Prevention. It is especially common in people aged 65 or older.
A recent agreement between humane and based in Nashville Monogram Health aims to help these adults manage this chronic disease. Monogram Health is a home-based provider of nephrology, primary care, and benefits management services for patients with chronic kidney disease and end-stage kidney disease.
The value-based partnership is for Humana Medicare Advantage HMO and PPO plan members with chronic kidney disease who live in Tennessee, Alabama, Mississippi and Louisiana. These members can access Monogram’s specialty care resources, such as home primary and specialty care visits, medication management, dialysis, and social services.
In addition to treating kidney disease, Monogram’s clinical staff also treat patients’ existing comorbidities, said Michael Uchrin, the company’s CEO and co-founder.
“People with kidney disease have a very high prevalence of cardiovascular disease, hypertension, and diabetes,” Uchrin said in an interview. “As we address the treatment of an individual’s kidney disease, we also address all of their other conditions to ensure an appropriate evidence-based treatment plan.”
Providing this care in patients’ homes makes all the difference, Uchrin added. It helps reach underserved populations who may have struggled to receive kidney care in the past.
“We’re going to underserved communities where they’ve had challenges in terms of transportation…It really allows us to really transform the patient experience and break down the barriers, many of which are defining social barriers to the access to care,” said Uchrin.
Humana and Monogram have had a relationship since 2019. But the new partnership is transitioning to an entirely value-based model in which Monogram is paid based on quality of care rather than quantity. By doing this, Humana hopes to improve health outcomes for the patients it serves, said Carl Daley, senior vice president of retail strategy and operations for the insurer. The companies did not provide additional information on the specific results in place to gauge the success of the program.
“Millions of Americans have chronic kidney disease and that number continues to grow,” Daley said in an interview. “We felt it was essential to create access to evidence-based medicine, especially kidney care, and other services for our members.”
Uchrin said he had three major goals while working with Humana. The first is to increase access to care for chronic kidney disease, which is largely asymptomatic. Second, he hopes to ensure adherence to evidence-based care. Finally, he wants to improve the experience of patients receiving care.
“We need to get into the 21st century here in terms of patient experience and in a world where you have Amazon, you have UberEats, where goods and services are received and delivered to people’s homes for the most part,” he said. he declares. “Why is health care different and especially for the sickest and most vulnerable among us?”
Other value-driven kidney care providers include Strive for health and somatus.
Photo: Kiwis, Getty Images